Highfields Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
|
|||||
2019
Q1 | $83M | Sell |
|
|||||
2018
Q4 | $182M | Sell |
|
|||||
2018
Q3 | $303M | Sell |
|
|||||
2018
Q2 | $659M | Sell |
|
|||||
2018
Q1 | $636M | Buy |
|
|||||
2017
Q4 | $659M | Buy |
|
|||||
2017
Q3 | $450M | Buy |
|
|||||
2017
Q2 | $710M | Buy |
|
|||||
2017
Q1 | $569M | Buy |
|
|||||
2016
Q4 | $611M | Buy |
|
|||||
2016
Q3 | $376M | Sell |
|
|||||
2016
Q2 | $681M | Buy |
|
|||||
2016
Q1 | $513M | Buy |
|
|||||
2015
Q4 | $557M | Buy |
|
|||||
2015
Q3 | $468M | Buy |
|
|||||
2015
Q2 | $264M | Sell |
|
|||||
2015
Q1 | $317M | Hold |
|
|||||
2014
Q4 | $292M | Sell |
|
|||||
2014
Q3 | $343M | Buy |
|
|||||
2014
Q2 | $324M | Buy |
|
|||||
2014
Q1 | $317M | Buy |
|
|||||
2013
Q3 | – | Sell |
|
|||||
2013
Q2 | $60.4M | Buy |
|